Pavel Strnad is a full professor and leading physician at the University Hospital Aachen, Germany. Since 2008, he is heading his own research lab focusing on translational gastroenterology. In 2016, he was named one of the Rising Stars of the United European Gastroenterology. He is heading the European initiative for study of alpha1-antitrypsin deficiency-associated liver disease. His interests include metabolic liver disease, liver cirrhosis and complications as well as analysis of complex datasets. His clinical focus is on emerging drugs, end-stage liver disease and liver transplantation.